Literature DB >> 35107170

New developments in the prospects for GLP-1 therapy.

Stefan Trapp1, S Clare Stanford1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35107170      PMCID： PMC8820181          DOI： 10.1111/bph.15788

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   9.473


× No keyword cloud information.
  17 in total

Review 1.  The role of glia in the physiology and pharmacology of glucagon-like peptide-1: implications for obesity, diabetes, neurodegeneration and glaucoma.

Authors:  Qi N Cui; Lauren M Stein; Samantha M Fortin; Matthew R Hayes
Journal:  Br J Pharmacol       Date:  2021-11-23       Impact factor: 8.739

Review 2.  The diverse effects of brain glucagon-like peptide 1 receptors on ingestive behaviour.

Authors:  Diana L Williams
Journal:  Br J Pharmacol       Date:  2021-06-18       Impact factor: 8.739

3.  Central and peripheral GLP-1 systems independently suppress eating.

Authors:  Daniel I Brierley; Marie K Holt; Arashdeep Singh; Alan de Araujo; Molly McDougle; Macarena Vergara; Majd H Afaghani; Shin Jae Lee; Karen Scott; Calyn Maske; Wolfgang Langhans; Eric Krause; Annette de Kloet; Fiona M Gribble; Frank Reimann; Linda Rinaman; Guillaume de Lartigue; Stefan Trapp
Journal:  Nat Metab       Date:  2021-02-15

Review 4.  Glucagon-like peptide-1 (GLP-1) signalling in the brain: From neural circuits and metabolism to therapeutics.

Authors:  Anita Kabahizi; Briana Wallace; Linh Lieu; Dominic Chau; Yanbin Dong; Eun-Sang Hwang; Kevin W Williams
Journal:  Br J Pharmacol       Date:  2021-11-04       Impact factor: 8.739

Review 5.  Actions of glucagon-like peptide-1 receptor ligands in the gut.

Authors:  Jens Juul Holst; Daniel Bjørklund Andersen; Kaare Villum Grunddal
Journal:  Br J Pharmacol       Date:  2021-08-04       Impact factor: 8.739

Review 6.  Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?

Authors:  Tito Borner; Ian C Tinsley; Robert P Doyle; Matthew R Hayes; Bart C De Jonghe
Journal:  Br J Pharmacol       Date:  2021-09-14       Impact factor: 8.739

Review 7.  Reappraising the role of the vagus nerve in GLP-1-mediated regulation of eating.

Authors:  Daniel I Brierley; Guillaume de Lartigue
Journal:  Br J Pharmacol       Date:  2021-07-31       Impact factor: 8.739

Review 8.  The therapeutic potential of GLP-1 receptor biased agonism.

Authors:  Ben Jones
Journal:  Br J Pharmacol       Date:  2021-05-20       Impact factor: 8.739

9.  Normalisation of glucose metabolism by exendin-4 in the chronic phase after stroke promotes functional recovery in male diabetic mice.

Authors:  Ingrid Lovise Augestad; Doortje Dekens; Dimitra Karampatsi; Osama Elabi; Alexander Zabala; Hiranya Pintana; Martin Larsson; Thomas Nyström; Gesine Paul; Vladimer Darsalia; Cesare Patrone
Journal:  Br J Pharmacol       Date:  2021-06-16       Impact factor: 8.739

Review 10.  Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment.

Authors:  Stefan Trapp; Daniel I Brierley
Journal:  Br J Pharmacol       Date:  2021-08-28       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.